| __timestamp | Bio-Techne Corporation | HUTCHMED (China) Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 357763000 | 91813000 |
| Thursday, January 1, 2015 | 452246000 | 178203000 |
| Friday, January 1, 2016 | 499023000 | 216080000 |
| Sunday, January 1, 2017 | 563003000 | 241203000 |
| Monday, January 1, 2018 | 642993000 | 214109000 |
| Tuesday, January 1, 2019 | 714006000 | 204890000 |
| Wednesday, January 1, 2020 | 738691000 | 227976000 |
| Friday, January 1, 2021 | 931032000 | 356128000 |
| Saturday, January 1, 2022 | 1105599000 | 426409000 |
| Sunday, January 1, 2023 | 1136702000 | 837999000 |
| Monday, January 1, 2024 | 1159060000 |
Unleashing the power of data
In the dynamic world of biotechnology, revenue growth is a key indicator of a company's success and market position. Over the past decade, Bio-Techne Corporation has demonstrated a robust upward trajectory, with its revenue increasing by over 220% from 2014 to 2023. This growth reflects the company's strategic investments and innovations in the biotech field. In contrast, HUTCHMED (China) Limited, while showing a significant revenue increase of approximately 810% during the same period, experienced a more volatile growth pattern. Notably, HUTCHMED's revenue surged dramatically in 2023, reaching nearly 74% of Bio-Techne's revenue, highlighting its potential in the competitive biotech landscape. However, data for 2024 is missing for HUTCHMED, leaving room for speculation about its future performance. This comparison underscores the diverse growth strategies and market dynamics within the biotech industry.
Johnson & Johnson and Bio-Techne Corporation: A Comprehensive Revenue Analysis
AbbVie Inc. and HUTCHMED (China) Limited: A Comprehensive Revenue Analysis
Annual Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Bio-Techne Corporation
Comparing Revenue Performance: Takeda Pharmaceutical Company Limited or HUTCHMED (China) Limited?
Revenue Insights: argenx SE and Bio-Techne Corporation Performance Compared
Bio-Techne Corporation vs Walgreens Boots Alliance, Inc.: Examining Key Revenue Metrics
Revenue Insights: Bio-Techne Corporation and Exelixis, Inc. Performance Compared
Breaking Down Revenue Trends: Bio-Techne Corporation vs Pharming Group N.V.
Revenue Insights: Bio-Techne Corporation and Grifols, S.A. Performance Compared
Annual Revenue Comparison: Bio-Techne Corporation vs Ionis Pharmaceuticals, Inc.
Bio-Techne Corporation vs Ligand Pharmaceuticals Incorporated: Annual Revenue Growth Compared
Lantheus Holdings, Inc. or HUTCHMED (China) Limited: Who Leads in Yearly Revenue?